Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic urticaria: what problems for the physicians?].

E Collet1

  • 1Service de Dermatologie, Hôpital du Bocage, 2, boulevard du Maréchal de Lattre de Tassigny, 21000 Dijon.

Annales De Dermatologie Et De Venereologie
|July 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

French national protocol for diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in adults and children.

Annales de dermatologie et de venereologie·2025
Same author

A case of ichtyosiform and morpheaform sarcoidosis.

Annales de dermatologie et de venereologie·2022
Same author

Out-of-equilibrium dynamics driven by photoinduced charge transfer in CsCoFe Prussian blue analogue nanocrystals.

Faraday discussions·2022
Same author

Strain wave pathway to semiconductor-to-metal transition revealed by time-resolved X-ray powder diffraction.

Nature communications·2021
Same author

Photoselective MLCT to d-d pathways for light-induced excited spin state trapping.

The Journal of chemical physics·2019
Same author

Comparison of structural dynamics and coherence of d-d and MLCT light-induced spin state trapping.

Chemical science·2017
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Chronic urticaria, often idiopathic, causes significant distress. While infections and thyroid autoimmunity are linked, second-generation antihistamines are the primary treatment for this disabling skin condition.

Area of Science:

  • Dermatology
  • Immunology
  • Internal Medicine

Background:

  • Chronic urticaria is a prevalent and debilitating skin condition.
  • Diagnosis relies on anamnesis and clinical investigations.
  • Potential triggers include infections (bacterial, viral, parasitic) and thyroid autoimmunity.

Purpose of the Study:

  • To review the diagnosis and management of chronic urticaria.
  • To explore potential associations with infections and autoimmune conditions.
  • To outline current treatment strategies and their limitations.

Main Methods:

  • Review of existing literature on chronic urticaria.
  • Analysis of diagnostic approaches including clinical evaluation and biopsy.
  • Evaluation of treatment efficacy for different patient subgroups.

Related Experiment Videos

Main Results:

  • 60-80% of chronic urticaria cases remain idiopathic despite investigations.
  • Associations with Helicobacter pylori, hepatitis C virus, Toxocara canis, and thyroid autoimmunity are suggested.
  • Extensive screening for underlying causes is generally not recommended.

Conclusions:

  • Second-generation H1-antihistamines are the first-line treatment for chronic idiopathic urticaria.
  • Combined antihistamine therapies can be effective.
  • Systemic corticosteroids and immunosuppressants are reserved for severe cases due to toxicity.